ATC level 4
L01FDCancer medicines (antineoplastics), subgroup L01F, subgroup L01FD
- Molecules
- 5
- Subgroups
- 5
ATC L01FD (Cancer medicines (antineoplastics), subgroup L01F, subgroup L01FD) is a level 4 group in the anatomical therapeutic chemical classification. The catalogue lists 5 molecules in it, each with brands, manufacturers and supply from India.
ATC codes are used as identifiers. Class names are written by MedsAcross and are not the WHO Collaborating Centre's text.
Subgroups
Molecules
Molecules with an ATC code under L01FD.
- PertuzumabBiologicHER2/neu Receptor Antagonist1 presentation3 brandsL01FD02
- TrastuzumabOrphanHER2/neu Receptor Antagonist14 presentations18 brandsL01FD01
- Trastuzumab deruxtecanBiologic1 presentation2 brandsL01FD04
- Trastuzumab emtansineBiologic1 presentation2 brandsL01FD03
- ZanidatamabOrphanBispecific HER2-directed Antibody1 presentation2 brandsL01FD07
For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Cannot find the medicine you need?
Our sourcing team can find unlisted, unapproved and hard-to-find medicines through licensed channels.